Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of…
Read MoreRoche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of…
Read MoreChina counted more than 10,000 fresh COVID cases on Friday sparking further restrictions on movement,…
Read MoreChina counted more than 10,000 fresh COVID cases on Friday sparking further restrictions on movement,…
Read MoreNovavax Inc. on Tuesday tweaked its full-year sales outlook to the low end of its…
Read MoreProtests in northeastern China against the government’s zero-COVID policy became violent, as seven people were…
Read MoreFirst the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data…
Read MoreModerna Inc. shares moved lower Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter…
Read MoreTandem Diabetes Care Inc. shares plummeted more than 20% after the company reported earnings Wednesday,…
Read MoreEli Lilly & Co. Inc.’s LLY, -2.57% steady transformation into a developer of both cutting-edge…
Read MoreHospitalizations are rising again in New York City with the spread of new COVID-19 subvariants…
Read More